Featured Research

from universities, journals, and other organizations

Diabetes Drugs May Help Multiple Sclerosis Sufferers

Date:
June 10, 2002
Source:
University Of Illinois At Chicago
Summary:
Drugs currently used to treat Type 2 diabetes may also prove useful for treatment of multiple sclerosis, according to studies at the University of Illinois at Chicago and the West Side Veterans Administration Hospital. The results are published in the June issue of the journal Annals of Neurology.

Drugs currently used to treat Type 2 diabetes may also prove useful for treatment of multiple sclerosis, according to studies at the University of Illinois at Chicago and the West Side Veterans Administration Hospital. The results are published in the June issue of the journal Annals of Neurology.

Related Articles


Douglas Feinstein, a research associate professor of anesthesiology at UIC, says two antidiabetic drugs called thiazolidinediones, or TZDs, already approved by the Food and Drug Administration for treatment of Type 2 diabetes, prevented the development of an animal model of MS in the studies.

Other tests, already under way, are designed to test if the drugs could also be effective in other neurologic diseases, including Alzheimer's, Parkinson's and stroke, he says.

The drugs prevented the MS-like disease known as experimental autoimmune encephalomyelitis from occurring in healthy mice and reduced symptoms when given to mice that were already ill. Moreover, the drugs were effective in two different models of the disease, a chronic form in which the mice became ill and remained sick and a model in which the mice developed a relapsing form of the disease, which is similar to the more prevalent form of MS.

The antidiabetic TZDs used in the study were originally developed to increase the body's sensitivity to the low levels of insulin present in Type 2 diabetes. Rather than influencing the amount of insulin in the body, these insulin-sensitizing drugs increase the ability of cells and tissue to take up the correct amount of glucose, Feinstein explains.

However, more recent studies demonstrate that the drugs carry out other actions, he says. The drugs prevent the activation and growth of lymphocytes and reduce the production of inflammatory substances by activated brain cells. He and his colleagues believe this may be the primary way the drugs act to reduce the symptoms of MS in mice.

MS is believed to result from increased production of inflammatory immune proteins. This immune activity causes damage to myelin, the substance that insulates nerve fibers, along with nerve fibers themselves.

"The causes of MS are not completely understood," Feinstein says. "However, it is known that activated lymphocytes in the bloodstream enter the brain, where they produce toxic substances that eventually cause damage to the myelin-forming cells of the brain [the oligodendrocytes] and to neurons as well. In addition, once in the brain, the lymphocytes activate resident brain cells that further increase the production of toxic substances."

Feinstein is now designing a clinical trial to test the safety and proper dosage of the drugs in MS patients. He hopes to start that trial within a year.

Even if the drugs are only as good as those currently in use, they still offer an advantage for patients because they can be taken orally.

"The minimum we're hoping for is that they will be as good as any of the existing drugs," Feinstein says. "But there's a possibility they could prove to be better because this is a different class of drugs with different targets and effects."

The study involved collaborations with researchers at several other universities and hospitals, including Dr. Michael Heneka of the University of Bonn in Germany, and was supported by a grant from the National Multiple Sclerosis Society.

Feinstein's journal article can be found at http://www3.interscience.wiley.com/cgi-bin/abstract/93521194/START

For more information about UIC, visit http://www.uic.edu


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "Diabetes Drugs May Help Multiple Sclerosis Sufferers." ScienceDaily. ScienceDaily, 10 June 2002. <www.sciencedaily.com/releases/2002/06/020610074105.htm>.
University Of Illinois At Chicago. (2002, June 10). Diabetes Drugs May Help Multiple Sclerosis Sufferers. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2002/06/020610074105.htm
University Of Illinois At Chicago. "Diabetes Drugs May Help Multiple Sclerosis Sufferers." ScienceDaily. www.sciencedaily.com/releases/2002/06/020610074105.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins